While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition to the leading FreeStyle Libre continuous glucose monitor (CGM) platform, ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin delivery feature to predict and help prevent high and low blood sugar.

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.